News Column

Parexel Rebrands Its Technology Subsidiary Parexel Informatics and Retains Perceptive Brand

February 18, 2014

Parexel International Corp., a biopharmaceutical services provider, announced that Perceptive Informatics, the Parexel subsidiary that provides the Perceptive MyTrials eClinical platform and other clinical development technology solutions, has been rebranded Parexel Informatics.

According to a release, the Perceptive brand will be used to identify specific Parexel Informatics offerings, including the Perceptive MyTrials eClinical platform, the Perceptive Partner Program and the Perceptive Institute.

This alignment further supports the Company's ability to meet demand from biopharmaceutical companies for integrated services, as well as underscoring Parexel's ability to offer a more seamless technology and services portfolio to clients around the world.

"As biopharmaceutical companies increasingly seek a combination of solutions from a single service provider, we are more closely integrating our clinical research and technology offerings to meet this need," said Mark A. Goldberg, President and Chief Operating Officer, Parexel. "Toward that end, the new Parexel Informatics branding communicates our commitment to providing technology-driven solutions that complement our other clinical trial services, without changing our overall go-to-market strategy. At the same time, we'll continue to use the respected Perceptive brand with certain offerings in recognition of the considerable market equity it has earned over the years."

Parexel Informatics is a eClinical solutions provider that provides Software-as-a-Service (SaaS) applications and technology services to accelerate the drug development process.

"As bringing new drugs to market becomes more complex, particularly in today's global market, companies are relying more on technology to gain a competitive advantage," said Xavier Flinois, President of Parexel Informatics. "Parexel Informatics helps our clients worldwide simplify and accelerate the drug development process by offering industry-leading technology and services in the context of Parexel's deep clinical expertise and global reach."

More information:

((Comments on this story may be sent to

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Professional Services Close - Up

Story Tools